An ayurvedic medicine to treat dengue is undergoing the third and final phase of clinical trials and will be launched within the next two years, a senior official of the Ayush Ministry said on Tuesday.
Ayush Secretary Vaidya Rajesh Kotecha said the research on this was being carried out by Ayush (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy) Ministry and the Indian Council of Medical Research (ICMR).
It is made of a variety of ayurvedic herbs grown in India and is likely to hit the market within the next two years in the form of a pill.
"The research is in the third phase (final phase) of clinical trial. It will be done in the next two years. Once finished, this will be the world's first medicine against dengue," he said on the sidelines of a press conference on the achievements of the ministry in the last 100 days.
Details, such as the name of the medicine, how it will be sold - over the counter or through prescription - are yet to be decided. The ICMR and the ministry team will also have to work to standardise the dosage and fix the proportion of each herb used.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
